Precigen Inc (PGEN)

04:01 AM

How to integrate Precigen Inc. into portfolio analysis toolsJuly 2025 Breakouts & Verified Entry Point Signals - newser.com

04:01 AM

01:25 AM

What technical models suggest about Precigen Inc.’s comebackM&A Rumor & Safe Entry Point Identification - newser.com

01:25 AM

01:12 AM

Can Precigen Inc. stock deliver strong Q4 earnings2025 Dividend Review & Real-Time Buy Signal Notifications - Trung tâm Dự báo KTTV quốc gia

01:12 AM

12:25 PM

A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis - Yahoo Finance

12:25 PM

Oct 16, 2025

Precigen, Inc. Hits Day High with 10.31% Surge in Strong Intraday Performance - Markets Mojo

Oct 16, 2025

Oct 16, 2025

Patient Capital's Q3 2025 Top Contributors And Detractors - Seeking Alpha

Oct 16, 2025

Oct 15, 2025

Why Precigen Inc. stock appeals to dividend seekersJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com

Oct 15, 2025

Oct 14, 2025

How Precigen Inc. stock performs in high volatility marketsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

Will a bounce in Precigen Inc. offer an exitGap Up & Fast Entry Momentum Trade Alerts - newser.com

Oct 14, 2025

Oct 13, 2025

Institutional scanner results for Precigen Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com

Oct 13, 2025

Oct 13, 2025

Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes - MarketScreener

Oct 13, 2025

Oct 13, 2025

Precigen reports durable responses to RRP treatment in long-term data - Investing.com Canada

Oct 13, 2025

Oct 13, 2025

Precigen reports durable responses to RRP treatment in long-term data By Investing.com - Investing.com South Africa

Oct 13, 2025

Oct 13, 2025

Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre - GuruFocus

Oct 13, 2025

Oct 13, 2025

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis - Yahoo Finance

Oct 13, 2025

Oct 10, 2025

Using flow based indicators on Precigen Inc.Market Volume Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Analyzing recovery setups for Precigen Inc. investorsWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Precigen (NASDAQ:PGEN) - MarketBeat

Oct 10, 2025

Oct 10, 2025

How to monitor Precigen Inc. with trend dashboardsJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com

Oct 10, 2025

Oct 10, 2025

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem With 158% Upside Potential - DirectorsTalk Interviews

Oct 10, 2025

Oct 09, 2025

Minimal Residual Disease Pipeline 2025: Pioneering Clinical Developments by 8+ Global Innovators – DelveInsight | Highlighting Genentech, AmMax Bio, Elicio Therapeutics, Precigen Inc - Barchart.com

Oct 09, 2025

Oct 09, 2025

Will Precigen Inc. stock deliver long term returns2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Why Precigen Inc. stock is seen as undervaluedJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com

Oct 09, 2025

Oct 09, 2025

Will Precigen Inc. stock deliver consistent dividendsMarket Trend Review & Low Drawdown Trading Techniques - newser.com

Oct 09, 2025

Oct 08, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 08, 2025

Oct 07, 2025

Precigen (NASDAQ:PGEN) Trading 5.6% HigherStill a Buy? - MarketBeat

Oct 07, 2025

Oct 06, 2025

Chart based analysis of Precigen Inc. trends2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Is Precigen Inc. stock ready for a breakoutJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com

Oct 06, 2025

Oct 05, 2025

Volatility clustering patterns for Precigen Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com

Oct 05, 2025

Oct 04, 2025

Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World

Oct 04, 2025

Oct 03, 2025

Have Precigen Insiders Been Selling Stock? - 富途牛牛

Oct 03, 2025

Oct 03, 2025

Precigen, Inc. (PGEN) Stock Analysis: A 147.75% Upside Beckons Biotech Investors - DirectorsTalk Interviews

Oct 03, 2025

Oct 03, 2025

What machine learning models say about Precigen Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Oct 03, 2025

Oct 01, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Oct 01, 2025

Oct 01, 2025

Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus

Oct 01, 2025

Oct 01, 2025

Precigen (NASDAQ:PGEN) Director Sells $243,082.80 in Stock - MarketBeat

Oct 01, 2025

Oct 01, 2025

Jeffrey Kindler Sells 106,837 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat

Oct 01, 2025

Oct 01, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - MSN

Oct 01, 2025